Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ortataxel in taxane-resistant NSCLC
NCT00044538Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ortataxel in non-small cell lung cancer (NSCLC), sponsored by Bayer. Started Dec 2001; status: completed.
02
Drugs
ortataxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00044538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044538.